Page last updated: 2024-11-03

riluzole and Cerebral Infarction, Middle Cerebral Artery

riluzole has been researched along with Cerebral Infarction, Middle Cerebral Artery in 2 studies

Riluzole: A glutamate antagonist (RECEPTORS, GLUTAMATE) used as an anticonvulsant (ANTICONVULSANTS) and to prolong the survival of patients with AMYOTROPHIC LATERAL SCLEROSIS.

Research Excerpts

ExcerptRelevanceReference
"Mice were subjected to transient middle cerebral artery occlusion (1 h) and reperfusion according to the intraluminal filament model."1.33Alpha-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia. ( Blondeau, N; Heurteaux, C; Jarretou, G; Laigle, C; Lazdunski, M, 2006)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ren, L1
Fang, Yn1
Zhang, Aw1
Li, Xl1
Wang, Xj1
Yin, Z1
Miao, Jy1
Heurteaux, C1
Laigle, C1
Blondeau, N1
Jarretou, G1
Lazdunski, M1

Other Studies

2 other studies available for riluzole and Cerebral Infarction, Middle Cerebral Artery

ArticleYear
Effect of electroacupuncture on the expression of Nav1.1 in rat after acute cerebral ischemia.
    Neurological research, 2010, Volume: 32, Issue:7

    Topics: Analysis of Variance; Animals; Brain; Electroacupuncture; Fluorescent Antibody Technique; Infarction

2010
Alpha-linolenic acid and riluzole treatment confer cerebral protection and improve survival after focal brain ischemia.
    Neuroscience, 2006, Volume: 137, Issue:1

    Topics: alpha-Linolenic Acid; Animals; Blotting, Western; Brain; Cell Survival; Drug Therapy, Combination; I

2006